Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM
IRVINE, CA / ACCESSWIRE / September 4, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced...
Bionic
LIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation
GENEVA, Aug. 27, 2024 /PRNewswire/ -- As part of their Healthcare investment platform, LIAN Group, an innovative investor and operator...
Beta Bionics Celebrates Milestone: 10,000th iLet Patient
CONCORD, MA / ACCESSWIRE / August 15, 2024 / Beta Bionics, a commercial-stage medical technology company, proudly announces the 10,000th...
Bionic Health Accelerates National Expansion, Aiming to Add 1 Million Healthy Years to Americans’ Lives
RESEARCH TRIANGLE PARK, N.C., Aug. 14, 2024 /PRNewswire/ -- Bionic Health, a North Carolina-based preventative healthcare company, announced a rapid...
Embla Medical hf: The Centers for Medicare & Medicaid Services (CMS) grants extended coverage in the U.S. for lower-limb active K2 amputee patients to access bionic prosthetic solutions
REYKJAVIK, Iceland and COPENHAGEN, Denmark, July 18, 2024 /PRNewswire/ -- Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of...
Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in Diabetes Management
SHENZHEN, China, July 12, 2024 /PRNewswire/ -- On July 5th, the 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx),...
Exoskeleton Market to Surpass USD 23.6 Billion Valuation by 2031 On the Back of Rising Use of Exoskeletons in Healthcare and Industrial Applications | SkyQuest Technology
WESTFORD, Mass., July 3, 2024 /PRNewswire/ -- According to SkyQuest, the global Exoskeleton Market size was valued at USD 1.58 Billion...
Gareth Williams appointed CEO of Bionical Health
WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to...
Exoskeleton Market to be Worth $11.90 Billion by 2031 – Exclusive Report by Meticulous Research®
REDDING, Calif., June 6, 2024 /PRNewswire/ -- According to a new market research report titled, 'Exoskeleton Market by Product (Soft,...
65 Startups Named to MedTech Innovator 2024 Cohort
Now in its 12th year, the world’s largest medtech accelerator continues to identify the most promising medical device, diagnostic, and...
Bionic Power Launches $500,000 Agilik Movement Campaign on GoFundMe
The Agilik Movement is a community-building campaign to crowdfund Agilik (TM) smart orthoses for children and teens with knee-extension deficiencies.Vancouver,...
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
For development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump...
Trella Health Enhances Marketscape Insights for HME and Infusion Organizations with the Addition of Claim and Patient Counts
HME and Infusion organizations can maximize growth potential and strategically target top referral sources by leveraging patient and claim counts....
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation...
Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System
Beginning Dec. 18, iLet users will have the option of using a Dexcom G7 CGM System.CONCORD, MA / ACCESSWIRE /...
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies
CONCORD, MA / ACCESSWIRE / November 14, 2023 / Beta Bionics, Inc., a pioneering leader in the development of advanced...
Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence
CONCORD, MA / ACCESSWIRE / August 30, 2023 / Beta Bionics, Inc., a pioneering leader in the development of advanced...
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the...
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31,...
Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...